In a groundbreaking medical advancement, a New Jersey woman, Lisa Pisano, has received a second lease on life after undergoing a kidney transplant from a genetically modified pig. Pisano, 54, became the second person globally to receive such a transplant. Her physician, Dr. Robbery Montgomery of NYU Langone, expressed optimism about her recovery, stating that her new kidney is functioning exceptionally well. Pisano’s journey to receive this life-saving procedure began with years of health complications, including diabetes, multiple heart attacks, and kidney failure. As her condition worsened, she faced a grim reality, being within days of succumbing to her illness. Fortunately, she arrived at the hospital just in time to receive the transformative transplant. Along with the kidney, Pisano also received a thymus gland from the same pig, which aids in preventing organ rejection. Additionally, a pump was implanted to support her heart function. Expressing her amazement and gratitude, Pisano acknowledged that she initially did not believe this option was available to her. Her husband shared her sentiments, expressing his joy at seeing her smile again. The pig kidney has been a game-changer for Pisano, restoring her ability to engage in daily activities and spend quality time with her loved ones. She reflects on her previous state, where she felt limited and unable to participate fully in life. However, now, with her new lease on life, she can envision a brighter future. It is important to acknowledge that this innovative procedure is not without its critics. Some medical professionals and ethicists raise concerns about the use of expanded access protocols instead of formal clinical trials and the potential exploitation of vulnerable patients. Bioethicist Michael Gusmano emphasizes the need for caution and further research. Nonetheless, Pisano’s successful transplant underscores the immense potential of this medical breakthrough, offering hope to countless individuals facing the challenges of organ failure and lengthy waitlists.